TrialPancreas2014

LEADER 3--lipase and amylase activity in subjects with type 2 diabetes: baseline data from over 9000 subjects in the LEADER Trial.

William M Steinberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.